Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for Parkinson Disease in United States

252 results

Sort By:

Circuit-Based Deep Brain Stimulation for Parkinson's Disease P1A2&3 Catalyst

Study ID: NCT05658302
Start Date: 2023-03-28
End Date: 2028-03-01
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

30

Intervention / Treatment
Sponsor

University of Minnesota

Source: clinicaltrials.gov

Share:
Add to list

A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)

Study ID: NCT06841354
Start Date: 2025-03-16
End Date: 2030-05-18
Study Type

Interventional

Study Phase

Phase3

No. of Participants

1000

Intervention / Treatment

Sacituzumab tirumotecan

Pembrolizumab

Rescue Medication

Paclitaxel

Nab-paclitaxel

Gemcitabine

Carboplatin

Sponsor

Merck Sharp & Dohme LLC

Source: clinicaltrials.gov

Share:
Add to list

Neurophysiology of Locomotor Adaptation and Freezing of Gait in Parkinson's Disease

Study ID: NCT06911229
Start Date: 2025-08-01
End Date: 2028-12-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

60

Intervention / Treatment

Deep Brain Stimulation (DBS)

Sponsor

University of Florida

Source: clinicaltrials.gov

Share:
Add to list

High Frequency Light, Sound, and Tactile Stimulation to Improve Motor and Cognitive Deficits in Parkinson's Disease

Study ID: NCT05268887
Start Date: 2022-02-09
End Date: 2027-11
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

40

Intervention / Treatment

GENUS device (Active Settings)

GENUS device (Sham settings)

Sponsor

Massachusetts Institute of Technology

Source: clinicaltrials.gov

Share:
Add to list

Abbott DBS Post-Market Study of Outcomes for Indications Over Time

Study ID: NCT04071847
Start Date: 2019-11-26
End Date: 2030-09
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

1000

Intervention / Treatment

Deep Brain Stimulation (DBS)

Sponsor

Abbott Medical Devices

Source: clinicaltrials.gov

Share:
Add to list

Psilocybin Therapy for Depression in Parkinson's Disease

Study ID: NCT06455293
Start Date: 2024-08-19
End Date: 2028-06
Study Type

Interventional

Study Phase

Phase2

No. of Participants

60

Intervention / Treatment

Psilocybin

Sponsor

Joshua Woolley, M.D., PhD

Source: clinicaltrials.gov

Share:
Add to list

Slow Wave Sleep As a Biomarker of Rehabilitation-induced Cognitive Improvement in PD

Study ID: NCT04796506
Start Date: 2021-07-01
End Date: 2026-03-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

120

Intervention / Treatment

Progressive Resistance Training (PRT)

Delayed Exercise Training (DE)

Endurance Training (ET)

Sponsor

University of Colorado, Denver

Source: clinicaltrials.gov

Share:
Add to list

The Parkinson's Genetic Research Study

Study ID: NCT01558479
Start Date: 2009-09
End Date: 2026-10-31
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

5000

Intervention / Treatment
Sponsor

University of Washington

Source: clinicaltrials.gov

Share:
Add to list

A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's Disease

Study ID: NCT06765668
Start Date: 2025-02-12
End Date: 2026-08-06
Study Type

Interventional

Study Phase

Phase4

No. of Participants

220

Intervention / Treatment

CREXONT IS

Sponsor

Impax Laboratories, LLC

Source: clinicaltrials.gov

Share:
Add to list

Balance Tele-Rehab in Parkinson's Disease Parkinson's Disease

Study ID: NCT05680597
Start Date: 2022-09-19
End Date: 2027-06
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

80

Intervention / Treatment

Balance Tele-Rehabilitation Agility Boot Camp (ABC)

Sponsor

Oregon Health and Science University

Source: clinicaltrials.gov

Share:
Add to list